
도입처
Intuitive Surgical 로봇을 운영하는 조직 — 도입 기록 기준.
소개
https://www.intuitive.com/en-us/contact-us
로보틱스 미디어 및 하이라이트
주요 로보틱스 동영상
아직 주요 로보틱스 동영상이 없습니다
아직 동영상이 없습니다
이 회사에 연결된 주요 로보틱스 동영상이 없습니다.
로보틱스 스냅샷
등록된 주요 로보틱스 분야가 없습니다.
관련 뉴스

Teleoperated Humanoid Robots Successfully Perform Laparoscopic Surgery in Animal Trials
A research team at UC San Diego has successfully used a teleoperated humanoid robot to perform laparoscopic gallbladder removal in pigs, as highlighted in Nature Medicine on July 31, 2026. The research demonstrates the feasibility of using general-purpose humanoid morphology with standard surgical instruments for complex procedures, challenging the dominance of purpose-built surgical robots like Intuitive Surgical's Da Vinci system and potentially enabling surgical access in standard operating rooms without specialized equipment.

Johnson & Johnson Wins FDA Authorization for OTTAVA, the First Table-Integrated Surgical Robot
The United States Food and Drug Administration has granted De Novo authorization to Johnson & Johnson's OTTAVA Robotic Surgical System, the first soft tissue surgical robot with arms built directly into the operating table, clearing it for ten general surgery procedures and setting up the first serious architectural challenge to Intuitive Surgical's long-standing dominance.

FDA Clears Versius Plus for Six Gynaecological Procedures
CMR Surgical's Versius Plus won FDA 510(k) clearance for six benign gynaecological procedures, but the clearance excludes monopolar scissors and arrives as Stryker takes over the company's US sales operation.

Stryker Invests US$400 Million in CMR Surgical, Takes US Sales Lead
Stryker is investing US$400 million in CMR Surgical, gaining an exclusive option to acquire the rest of the company and exclusive U.S. sales rights for its Versius soft-tissue surgical robot.
관련 아티클

What a 14-Million-Procedure Study Says About da Vinci
A 14-million-procedure meta-analysis backed by Intuitive Surgical finds da Vinci robotic surgery beats open surgery on complications and mortality but shows no advantage over laparoscopic surgery, a distinction hospital capital committees should weigh before expanding robotic capacity.

The U.S. Is No Longer the First Market a Surgical Robot Conquers
Medtronic's latest Hugo clearance covers one instrument for one U.S. specialty, four years after the platform launched abroad. Across surgical robotics, FDA clearance now proceeds one procedure at a time, and it's made the United States the last major market platforms reach with full capability.

The Surgical Robotics Shakeout: A Bankruptcy, a Duopoly Test, and the Buyer's New Leverage
Surgical robotics just lost one of its most hyped startups to bankruptcy in the same week the premium market gained its first credible second supplier in a generation. This analysis maps the consolidation economics deciding who survives, China's parallel game, and a practical evaluation framework for hospitals entering the duopoly era.

What Is Physical AI?
Most people think AI lives inside computers and phones. That is no longer true. The moment AI gained sensors, motors, and the ability to act in physical space, its mistakes stopped being reversible. This affects every worker, patient, infrastructure manager, and policymaker whose environment now includes a machine that can move and decide. The question no one is answering clearly enough is: what exactly is physical AI, and why does it change the stakes so fundamentally?
제조 로봇: INTUITIVE SURGICAL
리더십
Gary Guthart (CEO)





